NHS

Showing 15 posts of 1081 posts found.

Akcea’s Tegsedi secures NICE approval for Stage 1 or 2 polyneuropathy in hATTR

May 23, 2019
Sales and Marketing Akcea Therapeutics, NHS, NICE, Tegsedi, UK, pharma

Akcea Therapeutics’ Tegsedi (inotersen) has received recommendation from NICE, the company has revealed, meaning the therapy will now be made …

GP appointments should be at least 15 minutes long by 2030, report argues

May 21, 2019
Manufacturing and Production, Medical Communications GP, NHS, UK, britain, pharma

GP consultations should be five minutes longer, with 10 minute doctors’ appointments being a ‘thing of the past,’ according to …

mental-health-3332122_960_720

Mental health spending varies dramatically among regions in England, analysis shows

May 14, 2019
Manufacturing and Production England, NHS, UK, mental health, mind, spending

Spending on mental health varies dramatically between regions in England, according to analysis from mental health charity Mind. South Yorkshire …

shutterstock_87495637

UK GPs are underequipped to handle growing chronic opioid use, report warns

May 13, 2019
Medical Communications, Sales and Marketing NHS, UK, opioid crisis, opioids, pharma

New research from the University of East Anglia (UEA) has argued that general practitioners (GPs) in the UK are lacking …

top_10_image

Top Ten most popular articles on Pharmafile.com this week!

May 10, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, GSK, Innoviva, NHS, Novartis, health, migraine, pharma

This week was a particularly bad one for the NHS after it was revealed thousands of EU nurses were leaving …

genentech_web

Ocrevus becomes first NICE-approved therapy on the NHS for primary progressive multiple sclerosis

May 9, 2019
Sales and Marketing Genentech, NHS, NICE, Ocrevus, UK

NICE has announced its final appraisal decision on Genentech’s Ocrevus (ocrelizumab), choosing to recommend the drug for use on the …

Thousands of EU nurses and midwives leave NHS because of Brexit

May 9, 2019
Medical Communications NHS, health, hospitals, midwifes, nurses

Nearly 5,000 EU nurses and midwifes have left the NHS over the past two years. The number of EU nationals …

Number of GPs in decline for first time in 50 years

May 8, 2019
Manufacturing and Production, Research and Development GP, NHS, pharma, public health

The number of GPs has been in decline, year on year, since 2014. The decline marks the first sustained fall …

Will mobile phones save the NHS?

May 7, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, UK, feature, mhealth, mobile health, pharma

The NHS is sick. According to politicians and NHS chiefs, the cure involves a strong dose of mHealth. Louis Goss …

Two thirds of MPs believe NHS should spend less on medicines

April 30, 2019
Manufacturing and Production Long Term Plan, MPs, NHS, UK, government, health, public health

Nearly two thirds (64%) of MPs believe the NHS should direct more resources towards prevention, over funding for new treatments, …

The price of access: Can the NHS afford Orkambi?

April 29, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, NHS, NICE, Orkambi, UK, Vertex, access, cystic fibrosis, feature, pharma, pricing

The impasse over access to Vertex’s Orkambi for cystic fibrosis patients in England and Wales has revealed the cracks in …

NICE recommends Akcea’s Tegsedi for rare, life-threatening progressive disease

April 17, 2019
Research and Development, Sales and Marketing Akcea, NHS, NICE, Tegsedi, UK

Akcea Therapeutics has shared the news that Tegsedi (inotersen), its antisense oligonucleotide (ASO) inhibitor of human transthyretin (TTR) production, has …

Half of patients have sub-optimal response to statins, research shows

April 16, 2019
Manufacturing and Production NHS, NICE, NICE guidelines, cholesterol, health, statins

Around half of patients who are prescribed statins do not see their cholesterol drop to desired levels within two years, …

28246711066_52e38bc591_z

NHS Confederation chief says news of Brexit extension is a relief

April 12, 2019
EU, NHS, UK, brexit, health, medicine

Niall Dickson, the Chief Executive of the NHS Confederation, has said news of the decision to extend the Brexit deadline …

novartis_window

Novartis’ Kisqali combo rejected by NICE for advanced breast cancer

April 11, 2019
Sales and Marketing Kisqali, NHS, NICE, Novartis, pharma

Novartis’ Kisqali (ribociclib) has been rejected for use on the NHS by NICE for the treatment of advanced breast cancer, …

Latest content